JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HOPPE, J. O.
Right arrow Articles by LANDS, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HOPPE, J. O.
Right arrow Articles by LANDS, A. M.
Journal of Pharmacology And Experimental Therapeutics, Vol. 97, Issue 3, 371-378, 1949
Copyright © 1949 by American Society for Pharmacology and Experimental Therapeutics


THE TOXICOLOGIC PROPERTIES OF N,N-DIMETHYL-N'-(3-THENYL)-N'-(2-PYRIDYL) ETHYLENEDIAMINE HYDROCHLORIDE (THENFADIL): A NEW ANTIHISTAMINIC DRUG

JAMES O. HOPPE 1 and A. M. LANDS 1

1 Biology Division of the Sterling-Winthrop Research Instituts, Rensselaer, New York

1. The acute intravenous toxicity of WIN 2848 was found to be similar to that of tripelennamine in mice, rats and rabbits, but significantly greater in hamsters. Both compounds were more toxic than diphenhydramine by intravenous, subcutaneous and intraperitoneal injection in mice. The acute oral toxicity of WIN 2848 in mice was similar to that of tripelennamine and diphenhydramine.

2. When administered subcutaneously to rats once daily, six days a week for three weeks, WIN 2848 caused no deaths at 5 and 10 mgm./kgm., one death at 20 mgm./kgm. after nineteen days of medication and killed all of the test animals by the twentieth day at 40 mgm./kgm. No significant effect on body weight was encountered at doses of 5, 10 and 20 mgm./kgm. No significant hematologic or pathologic changes were found.

3. WIN 2848 administered orally to dogs in doses of 5 and 10 mgm./kgm. once daily, six days a week for 90 days resulted in no deaths or loss in body weight. No significant changes were observed in hematology, blood glucose, non-protein nitrogen, blood chloride, albumin, globulin or total protein values. No tissue changes were found which could be attributed to the drug.

4. No signs of intoxication were observed upon repeated administration of 5 mgm./kgm. either subcutaneously in rats for three weeks or orally in dogs for three months. Evidence of cumulative toxicity was observed at doses of 10 and 20 mgm./kgm. upon subcutaneous administration in rats.

5. No evidence of cumulative toxicity was observed with oral medication in dogs at doses of 5 and 10 mgm./kgm.

6. The signs of acute intoxication with WIN 2848 were, in general, similar to those of known, commercially available antihistaminic drugs.

7. The mean waking time of mice from Evipal-induced sleep was prolonged 8 per cent by WIN 2848, 11 per cent by tripelennamine and 43 per cent by diphenhydramine.

Submitted on August 8, 1949







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1949 by the American Society for Pharmacology and Experimental Therapeutics.